COLL
Collegium Pharmaceutical, Inc.
Platform & Compounding FCF
B-
68.8 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
6.1%
-
Operating Margin Trend
+5.49 pp/yr
-
5yr Avg ROE
15.0%
-
5yr Share-Count CAGR
-0.8%
-
5yr Revenue CAGR
29.6%
-
5yr EPS CAGR
-1.8%
-
Revenue-Growth Years (5)
4/5
-
5yr FCF Margin
37.1%
-
5yr FCF/NI Conversion
3.82x
-
Net Debt / EBITDA
1.33x
-
Interest Coverage (EBIT/Int)
2.13x
-
Altman Z-Score
1.68
Stability
Weight: 5%
B-
68
-
EPS Volatility (σ/μ)
0.32
-
Piotroski F-Score
7
-
Negative-Revenue Years (5)
1/5
2 of 2 gurus held; 1 added; 1 trimmed.
- Holders
- 2
- Avg Δ position
-
+207.9%
- New buys
- 0
- Full exits
- 0